Using multiple genetic variants as instrumental variables for modifiable risk factors
- PMID: 21216802
- PMCID: PMC3917707
- DOI: 10.1177/0962280210394459
"V体育2025版" Using multiple genetic variants as instrumental variables for modifiable risk factors
Abstract
Mendelian randomisation analyses use genetic variants as instrumental variables (IVs) to estimate causal effects of modifiable risk factors on disease outcomes. Genetic variants typically explain a small proportion of the variability in risk factors; hence Mendelian randomisation analyses can require large sample sizes. However, an increasing number of genetic variants have been found to be robustly associated with disease-related outcomes in genome-wide association studies. Use of multiple instruments can improve the precision of IV estimates, and also permit examination of underlying IV assumptions. We discuss the use of multiple genetic variants in Mendelian randomisation analyses with continuous outcome variables where all relationships are assumed to be linear. We describe possible violations of IV assumptions, and how multiple instrument analyses can be used to identify them. We present an example using four adiposity-associated genetic variants as IVs for the causal effect of fat mass on bone density, using data on 5509 children enrolled in the ALSPAC birth cohort study. We also use simulation studies to examine the effect of different sets of IVs on precision and bias. When each instrument independently explains variability in the risk factor, use of multiple instruments increases the precision of IV estimates. However, inclusion of weak instruments could increase finite sample bias. Missing data on multiple genetic variants can diminish the available sample size, compared with single instrument analyses. In simulations with additive genotype-risk factor effects, IV estimates using a weighted allele score had similar properties to estimates using multiple instruments. Under the correct conditions, multiple instrument analyses are a promising approach for Mendelian randomisation studies. Further research is required into multiple imputation methods to address missing data issues in IV estimation VSports手机版. .
"VSports在线直播" Figures
References
-
- Youngman LD, Keavney BD, Palmer A, et al. Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: test of causality by ‘Mendelian randomization’. Circulation 2000; 102(Supplement II): 31–32
-
- Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease. Int J Epidemiol 2003; 32: 1–22 - PubMed
-
- Thomas DC, Conti DV. Commentary: the concept of 'Mendelian randomization'. Int J Epidemiol 2004; 33: 21–25 - PubMed (V体育ios版)
-
- Davey Smith G. Capitalising on Mendelian randomization to assess the effects of treatment. James Lind Library, 2006 - "V体育安卓版" PMC - PubMed
-
- Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27(8): 1133–1163 - V体育平台登录 - PubMed
Publication types
"V体育官网" MeSH terms
- Actions (V体育平台登录)
- V体育ios版 - Actions
- V体育平台登录 - Actions
- V体育官网入口 - Actions
- Actions (VSports app下载)
Grants and funding
"VSports" LinkOut - more resources
Full Text Sources
